+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Uterine Cancer Drugs Market Research Reports

Endometrial Cancer - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Endometrial Cancer - Global Drug Forecast and Market Analysis to 2030

  • Report
  • May 2021
  • Global
From
Endometrial Cancer - Epidemiology Forecast to 2030 - Product Thumbnail Image

Endometrial Cancer - Epidemiology Forecast to 2030

  • Report
  • May 2021
  • 42 Pages
  • Global
From
Endometrial Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Endometrial Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 1759 Pages
  • Global
From
Anastrozole Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Anastrozole Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • March 2024
  • 105 Pages
  • Global
From
Hydroxyprogesterone Caproate Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Hydroxyprogesterone Caproate Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 103 Pages
  • Global
From
Cyclophosphamide Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Cyclophosphamide Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • February 2024
  • 89 Pages
  • Global
From
Megestrol Acetate Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Megestrol Acetate Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • Report
  • January 2024
  • 78 Pages
  • Global
From
17alpha-Hydroxyprogesterone Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

17alpha-Hydroxyprogesterone Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • January 2024
  • 88 Pages
  • Global
From
Hydroxyprogesterone Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Hydroxyprogesterone Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2023
  • 96 Pages
  • Global
From
Medroxyprogesterone Acetate Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Medroxyprogesterone Acetate Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • October 2023
  • 113 Pages
  • Global
From
Megestrol Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Megestrol Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • August 2023
  • 110 Pages
  • Global
From
Endometrial Cancer Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Endometrial Cancer Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2023
  • 125 Pages
  • Global
From
Endometrial Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Endometrial Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 532 Pages
  • Global
From
Uterine Cancer (Oncology) - Drugs in Development, 2021 - Product Thumbnail Image

Uterine Cancer (Oncology) - Drugs in Development, 2021

  • Report
  • April 2021
  • 110 Pages
  • Global
From
Megestrol acetate (CAS 595-33-5) Global Market Research Report 2024 - Product Thumbnail Image

Megestrol acetate (CAS 595-33-5) Global Market Research Report 2024

  • Report
  • April 2024
  • 50 Pages
  • Global
From
Medroxyprogesterone 17-acetate (CAS 71-58-9) Global Market Research Report 2024 - Product Thumbnail Image

Medroxyprogesterone 17-acetate (CAS 71-58-9) Global Market Research Report 2024

  • Report
  • April 2024
  • 50 Pages
  • Global
From
Anastrozole (CAS 120511-73-1) Global Market Research Report 2024 - Product Thumbnail Image

Anastrozole (CAS 120511-73-1) Global Market Research Report 2024

  • Report
  • April 2024
  • 50 Pages
  • Global
From
Cyclophosphamide (CAS 50-18-0) Global Market Research Report 2024 - Product Thumbnail Image

Cyclophosphamide (CAS 50-18-0) Global Market Research Report 2024

  • Report
  • April 2024
  • 50 Pages
  • Global
From
11a-Hydroxyprogesterone (CAS 80-75-1) Global Market Research Report 2024 - Product Thumbnail Image

11a-Hydroxyprogesterone (CAS 80-75-1) Global Market Research Report 2024

  • Report
  • April 2024
  • 50 Pages
  • Global
From
11B-Hydroxyprogesterone (CAS 600-57-7) Global Market Research Report 2024 - Product Thumbnail Image

11B-Hydroxyprogesterone (CAS 600-57-7) Global Market Research Report 2024

  • Report
  • April 2024
  • 50 Pages
  • Global
From
Loading Indicator

Uterine Cancer Drugs are medications used to treat cancer of the uterus. These drugs are used to reduce the size of tumors, reduce the spread of cancer cells, and reduce the risk of recurrence. Commonly used drugs include chemotherapy, hormone therapy, targeted therapy, and immunotherapy. Chemotherapy drugs are used to kill cancer cells, while hormone therapy drugs are used to block the hormones that can cause cancer cells to grow. Targeted therapy drugs are used to target specific cancer cells, while immunotherapy drugs are used to boost the body's immune system to fight cancer. Some of the major companies in the Uterine Cancer Drugs market include Pfizer, Merck, Novartis, AstraZeneca, and Eli Lilly. These companies are involved in the research, development, and production of drugs for the treatment of uterine cancer. Show Less Read more